Close Menu

coronary artery disease

The deal with Quest enables clinicians to order blood draws on patients through its facilities for testing with CardioDx's Corus CAD test.

In Nature this week: DNA methylation loss in certain oil palm trees, coronary artery disease meta-analysis, and more.

An international research consortium finds a genetic link between height and risk of coronary artery disease.

The data, presented at the American College of Cardiology meeting, showed that doctors referred only 4 percent of women with low Corus CAD scores for further cardiac evaluation.

A meta-analysis on tens of thousands of individuals suggests cholesterol-lowering statin drugs may be particularly beneficial for those genetically prone to heart disease.

In an SEC document, the company called current market conditions for an IPO unattractive. 

CardioDx Raises $35M

The financing will go toward further commercialization of its Corus CAD test, as well as other genomics tests for coronary artery disease. 

NEW YORK (GenomeWeb) – Results of a single-center retrospective study focusing on a predominately African-American patient population have added to mounting evidence that Corus CAD, CardioDx's gene expression-based coronary artery disease rule-out test, can help clinicians avoid unnecessary refer

NEW YORK (GenomeWeb) – Cardiovascular molecular diagnostics company CardioDx has raised $21 million toward a targeted goal of $25 million, it disclosed in a regulatory document filed on Wednesday.

NEW YORK (GenomeWeb) – CardioDx today announced that Aetna has established a clinical policy for the Corus CAD gene expression test for coronary artery disease.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.